Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

bioAffinity Technologies, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   10-K10-KS-1/A
Revenues  0.00.01,415.3
            Revenue growth   -100.0% 
Cost of goods sold  0.00.02,604.4
Gross profit  0.00.0-1,189.1
            Gross margin  90.3% -84.0%
Selling, general and administrative   [+]2.71.1994.3
Research and development  1.11.0 
Other operating expenses  0.10.1420.9
EBITDA   [+]-4.0-2.2 
            EBITDA margin  -83299.5% -184.0%
Depreciation and amortization  0.00.0 
EBIT   [+]-4.0-2.2-2,604.4
            EBIT margin  -83511.5% -184.0%
Interest expense, net   [+]0.40.5381.1
Other income (expense), net   [+]-3.8-3.6-4,280.5
Pre-tax income  -8.2-6.3-7,266.0
Income taxes  0.00.02.8
Net income  -8.2-6.3-7,268.7
            Net margin  -169771.2% -513.6%
   
Basic EPS   [+]($1.81)($2.36)($2.72)
Diluted EPS   [+]($1.81)($2.36)($2.72)
   
Shares outstanding (basic)   [+]4.52.72,674.9
Shares outstanding (diluted)   [+]4.52.72,674.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy